Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection

详细信息    查看全文

• 作者：N. Coppola (1)
  A. Marrone (2)
  M. Pisaturo (1)
  M. Starace (1)
  G. Signoriello (3)
  I. Gentile (4)
  L. E. Adinolfi (2)
  E. Sagnelli (1)
  R. Zampino (2)
  
• 刊名：European Journal of Clinical Microbiology & Infectious Diseases
• 出版年：2014
• 出版时间：April 2014
• 年：2014
• 卷：33
• 期：4
• 页码：559-567
• 全文大小：360 KB
• 参考文献：1. Tiollais P, Pourcel C, Dejean A (1985) The hepatitis B virus. Nature 317:489-95 CrossRef
  2. Dienstag JL (1993) Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85:439-62
  3. Kaczynski J, Hansson G, Wallerstedt S (1996) Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 73:128-32 CrossRef
  4. Filippini P, Coppola N, Pisapia R, Martini S, Marrocco C, Di Martino F, et al (2007) Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients. J Med Virol 79:1679-685
  5. Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S et al (1994) Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 21:159-66 CrossRef
  6. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A et al (1993) Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:1529-533 CrossRef
  7. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T et al (2000) Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 32:1106-110 CrossRef
  8. Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A et al (1994) Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74:2442- CrossRef
  9. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM et al (1995) Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 2:39-5 CrossRef
  10. Sagnelli E, Pasquale G, Coppola N, Scarano F, Marrocco C, Scolastico C et al (2004) Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 32:144-48 CrossRef
  11. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C et al (2006) Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 43:100-07 CrossRef
  12. Sheen IS, Liaw YF, Lin DY, Chu CM (1994) Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358-61 CrossRef
  13. Zampino R, Marrone A, Merola A, Trani B, Cirillo G, Karayiannis P et al (2009) Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth. J Med Virol 81:2012-020 mv.21560" target="_blank" title="It opens in new window">CrossRef
  14. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C et al (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-01 CrossRef
  15. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-01 CrossRef
  16. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N et al (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105-109 CrossRef
  17. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML et al (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100-104 CrossRef
  18. Zampino R, Coppola N, Cirillo G, Boemio A, Pisaturo M, Marrone A et al (2013) Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. J Viral Hepat 20:517-23 CrossRef
  19. Coppola N, Zampino R, Bellini G, Macera M, Marrone A, Pisaturo M et al (2013) Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C. Clin Gastroenetrol Hepatol. doi:10.1016/j.cgh.2013.05.008
  20. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-99 CrossRef
  21. Carosi G, Rizzetto M (2008) Treatment of chronic hepatitis B: recommendations from an Italian workshop. Dig Liver Dis 40:603-17 CrossRef
  22. Italian Association for the Study of the Liver; Italian Society of Infectious, Tropical Diseases; Italian Society for the Study of Sexually Transmitted Diseases (2010) Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. Dig Liver Dis 42:81-1 CrossRef
  23. Coppola N, Pisaturo M, Tonziello G, Sagnelli C, Sagnelli E, Angelillo IF (2012) Efficacy of pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis. BMC Infect Dis 12:357. doi:10.1186/1471-2334-12-357 CrossRef
  24. Coppola N, Tonziello G, Pisaturo M, Messina V, Guastafierro S, Fiore M et al (2011) Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings. J Med Virol 83:1909-916 mv.22199" target="_blank" title="It opens in new window">CrossRef
  25. Coppola N, Pisaturo M, Guastafierro S, Tonziello G, Sica A, Iodice V et al (2012) Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy. Dig Liver Dis 44:49-4 CrossRef
  26. Coppola N, Potenza N, Pisaturo M, Mosca N, Tonziello G, Signoriello G et al (2013) Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression. PLoS One 8:e65336. doi:10.1371/journal.pone.0065336 CrossRef
  27. Coppola N, Masiello A, Tonziello G, Pisapia R, Pisaturo M, Sagnelli C et al (2010) Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. J Viral Hepat 17:493-00
  28. Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD et al (2010) A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139:1586-592 CrossRef
  29. Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C et al (2013) Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol 11:1174-180 CrossRef
  30. Balagopal A, Thomas DL, Thio CL (2010) IL28B and the control of hepatitis C virus infection. Gastroenterology 139:1865-876 CrossRef
  31. Mathurin P, Thibault V, Kadidja K, Ganne-Carrié N, Moussalli J, El Younsi M et al (2000) Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 7:15-2 CrossRef
  32. Coppola N, Pisapia R, Tonziello G, Martini S, Imparato M, Piai G et al (2008) Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. Antivir Ther 13:307-18
  33. Liaw YF, Yeh CT, Tsai SL (2000) Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 95:2978-980 CrossRef
  34. Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A et al (2002) HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 36:1285-291 CrossRef
  35. Liaw YF, Chen YC, Sheen IS, Chien RN, Yeh CT, Chu CM (2004) Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 126:1024-029 CrossRef
  36. Sagnelli E, Coppola N, Marrocco C, Onofrio M, Sagnelli C, Coviello G et al (2006) Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course. J Clin Virol 35:317-0 CrossRef
  37. Sagnelli E, Coppola N, Pisaturo M, Pisapia R, Onofrio M, Sagnelli C, et al. (2006) Clinical and virological improvement of HBV or HCV related chronic hepatitis with concomitant HAV infection. Clin Infect Dis 42:1536-543
  38. Sagnelli E, Coppola N, Pisaturo M, Masiello A, Tonziello G, Sagnelli C et al (2009) HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. Hepatology 49:1090-097 CrossRef
  39. Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J et al (2008) The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection. J Hepatol 49:688-94 CrossRef
  40. Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS et al (2009) Peginterferon Alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology 136:496-04.e3 CrossRef
  41. Coppola N, Stanzione M, Messina V, Pisaturo M, De Pascalis S, Macera M et al (2012) Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection. J Viral Hepat 19:890-96 CrossRef
  42. Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH et al (2013) Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology 57:2134-142 CrossRef
  
• 作者单位：N. Coppola (1)
  A. Marrone (2)
  M. Pisaturo (1)
  M. Starace (1)
  G. Signoriello (3)
  I. Gentile (4)
  L. E. Adinolfi (2)
  E. Sagnelli (1)
  R. Zampino (2)
  
  1. Department of Mental Health and Public Medicine, Section of Infectious Diseases, Second University of Naples, Via L. Armanni 5, 80133, Naples, Italy
  2. Internal Medicine and Hepatology, Second University of Naples, Naples, Italy
  3. Department of Mental Health and Public Medicine, Section of Statistics, Second University of Naples, Naples, Italy
  4. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
  
• ISSN：1435-4373

文摘

The purpose of this investigation was to evaluate the role of IL28-B polymorphism in the clearance of hepatitis C virus (HCV) in chronic hepatitis B virus (HBV)/HCV coinfection during a long-term follow-up. Thirty-four consecutive patients with HBV surface antigen (HBsAg)-positive/anti-HCV-positive chronic hepatitis were retrospectively enrolled at their first liver biopsy (LB). For all patients, a documented clinical, serological and virological follow-up of at least 3?years (range 3-6?years) after LB and a sample of whole blood for genetic evaluation were available. Of the 24 patients with detectable serum HBV-DNA and HCV-RNA at their first observation, three cleared both HBV-DNA and HCV-RNA, 12 HCV-RNA and five HBV-DNA. Of the seven HBV DNA-positive/HCV RNA-negative patients at enrolment, three cleared HBV-DNA and one remained HBV DNA-positive and became HCV RNA-positive. All three HBV DNA-negative/HCV RNA-positive patients remained unchanged. Compared with the 12 patients with HCV persistence, the 15 patients who cleared HCV were younger, had lower serum alanine aminotransferase (ALT), HCV load, and histological activity index (HAI) and fibrosis score, more frequently had IL28-B CC variant, had been receiving an interferon-based treatment and less frequently cleared serum HBV-DNA. To investigate the relationship between the IL28-B variants and clearance of HCV, excluding the confounding effect of interferon-based treatment, the Mantel–Haenszel test was used, which indicated an association between HCV clearance and IL28-B variants (p--.009). In chronic HBV/HCV coinfection, a long-term follow-up showed a frequent spontaneous or treatment-related clearance of active replication of one or both viruses and identified the IL28-B CC genotype as an independent predictor of HCV clearance.